Anavex Life Sciences Corp (AVXL)

[hnbadger1]

From Alexendard07 on ST.email to IR.

You might have answered my question indirectly
when you say the information in yesterday's PR was
not "exclusive" which I could take to mean that the
information yesterday saying the trial was
successful in a second way to compliment the initial
method the company used in the December PR to
claim the trial was successful. Which then could be
viewed that yesterday's PR was meant to frame the
trial results in a manner that reflects the recent FDA
approval criteria for ALZ treatments, which is
fantastic if accurate, but I don't want to make my
own conclusions and assumptions so to add some
additional clarity could you please answer the
following three questions individually:
Is yesterday's PR meant to say the trial was
successful using the method outlined in the PR, in
addition to the method the company outlined in the
December PR to claim the trial was successful?

IR-We believe it was successful.

Does the company still maintain their position, as
claimed in the December PR, that ADSC-ADL was
statistically significant on its own?

IR-Yes

Why have the P-values changed for the same
endpoints in yesterday's PR than what was given in
the December PR?

IR- The end points have not
changed……there will be additional data to follow
which we believe will elaborate further.